The small molecule ZY-214-4 may reduce the virulence of Staphylococcus aureus by inhibiting pigment production

BMC Microbiol. 2021 Feb 27;21(1):67. doi: 10.1186/s12866-021-02113-5.

Abstract

Background: In recent years, clinical Staphylococcus aureus isolates have become highly resistant to antibiotics, which has raised concerns about the ability to control infections by these organisms. The aim of this study was to clarify the effect of a new small molecule, ZY-214-4 (C19H11BrNO4), on S. aureus pigment production.

Results: At the concentration of 4 μg/mL, ZY-214-4 exerted a significant inhibitory effect on S. aureus pigment synthesis, without affecting its growth or inducing a toxic effect on the silkworm. An oxidant sensitivity test and a whole-blood killing test indicated that the S. aureus survival rate decreased significantly with ZY-214-4 treatment. Additionally, ZY-214-4 administration significantly reduced the expression of a pigment synthesis-related gene (crtM) and the superoxide dismutase genes (sodA) as determined by real-time quantitative polymerase chain reaction (RT-qPCR) analysis. ZY-214-4 treatment also improved the survival rate of S. aureus-infected silkworm larvae.

Conclusions: The small molecule ZY-214-4 has potential for the prevention of S. aureus infections by reducing the virulence associated with this bacterium.

Keywords: Oxidation; Pigment; Sod; Staphylococcus aureus; crtM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Farnesyl-Diphosphate Farnesyltransferase / genetics
  • Gene Expression Regulation, Bacterial / drug effects
  • Pigmentation / drug effects*
  • Staphylococcus aureus / drug effects*
  • Superoxide Dismutase / genetics
  • Virulence / drug effects

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Superoxide Dismutase
  • CrtM protein, Staphylococcus aureus
  • Farnesyl-Diphosphate Farnesyltransferase